$97.50
Price
$19.5B
Market Cap
13.8
P/E Ratio
10.8
Forward P/E
$7.08
EPS (TTM)
—
Dividend Yield
$4.0B
Cash
$40M
Total Debt
200M
Shares Out
$63.93
$112.29
52-Week Range
Institutional Ownership of INCYTE CORP
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Sound Shore Management|Harry Burn
|
767.8K | $72M | $68.02 | +54.45% |
Trading Activity for INCYTE CORP
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| SELL | -17.4% | 767.8K | $72M | $101.06 | |
| 2025-Q4 | |||||
| BUY | +9.4% | 929.8K | $92M | $98.64 | |
| 2025-Q3 | |||||
| SELL | -4.5% | 13.9M | $1.2B | $82.70 | |
| SELL | -25.4% | 849.9K | $72M | $82.70 | |
| 2025-Q2 | |||||
| SELL | -1.8% | 14.6M | $994M | $62.66 | |
| SELL | -23.7% | 1.1M | $78M | $62.66 | |
| 2025-Q1 | |||||
| SELL | -0.4% | 14.9M | $900M | $71.27 | |
| BUY | +24.5% | 1.5M | $91M | $71.27 | |
| 2024-Q4 | |||||
| SELL | -2.3% | 14.9M | $1.0B | $70.39 | |
| BUY | +98.4% | 1.2M | $83M | $70.39 | |
| 2024-Q3 | |||||
| SELL | -0.0% | 15.3M | $1.0B | $64.12 | |
| BUY | NEW | 605.3K | $40M | $64.12 | |
| 2024-Q2 | |||||
| SELL | -0.9% | 15.3M | $926M | $56.92 | |
| 2024-Q1 | |||||
| SELL | -4.2% | 15.4M | $878M | $59.33 | |
| 2023-Q4 | |||||
| SELL | -2.0% | 16.1M | $1.0B | $55.10 | |
| 2023-Q3 | |||||
| SELL | -14.8% | 16.4M | $948M | $63.48 | |
| 2023-Q2 | |||||
| SELL | -0.3% | 19.3M | $1.2B | $64.55 | |
| 2023-Q1 | |||||
| SELL | -0.2% | 19.3M | $1.4B | $79.00 | |
| 2022-Q4 | |||||
| SELL | -2.2% | 19.4M | $1.6B | $77.45 | |
| 2022-Q3 | |||||
| SELL | -1.4% | 19.8M | $1.3B | $73.59 | |
| 2022-Q2 | |||||
| BUY | +11.1% | 20.1M | $1.5B | $75.51 | |
| 2022-Q1 | |||||
| BUY | +8.4% | 18.1M | $1.4B | $73.35 | |
| 2021-Q4 | |||||
| BUY | +1.1% | 16.7M | $1.2B | $66.32 | |
| 2021-Q3 | |||||
| BUY | +21.2% | 16.5M | $1.1B | $76.05 | |
| 2021-Q2 | |||||
| BUY | +214.9% | 13.6M | $1.1B | $83.12 | |
| 2021-Q1 | |||||
| BUY | +32.7% | 4.3M | $351M | $82.95 | |
| 2020-Q4 | |||||
| SELL | -1.1% | 3.3M | $283M | $86.34 | |
| 2020-Q3 | |||||
| SELL | -10.5% | 3.3M | $295M | $95.56 | |
| 2020-Q2 | |||||
| SELL | -8.0% | 3.7M | $382M | $97.02 | |
| 2020-Q1 | |||||
| BUY | +6.2% | 4.0M | $292M | $76.14 | |
| 2019-Q4 | |||||
| SELL | -3.9% | 3.8M | $328M | $86.14 | |
| 2019-Q3 | |||||
| SELL | -7.0% | 3.9M | $290M | $81.06 | |
| 2019-Q2 | |||||
| SELL | -1.1% | 4.2M | $358M | $80.50 | |
| 2019-Q1 | |||||
| BUY | +0.4% | 4.3M | $366M | $82.45 | |
| 2018-Q4 | |||||
| BUY | NEW | 4.2M | $270M | $64.86 | |
| 2018-Q2 | |||||
| SELL | EXIT | — | — | $67.89 | |
| 2018-Q1 | |||||
| BUY | +1.0% | 140.4K | $12M | $89.67 | |
Insider Trading for INCYTE CORP
6 Months Insider Sentiment
Buy $0
Sell $11.7M
0
Buys
11
Sells
-11.7M
Net
4
Grants
Largest
$5.2M
Morrissey
$2.1M
Stein
$1.6M
Stein
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 07, 2026 | Mohamed Khairie Issa | EVP, Head of US Oncology | SELL | 10.9K | $109.07 | $1.2M |
| Jan 05, 2026 | Steven H Stein | EVP & Chief Medical Officer | SELL | 15.6K | $101.70 | $1.6M |
| Dec 31, 2025 | BAKER BROS. ADVISORS LP | Director, 10% Owner | GRANT | 328 | — | — |
| Dec 31, 2025 | Edmund Harrigan | Director | GRANT | 245 | $98.77 | $24K |
| Dec 31, 2025 | Paul J Clancy | Director | GRANT | 241 | $98.77 | $24K |
| Dec 19, 2025 | Thomas Tray | Principal Accounting Officer | EXERCISE | 1.7K | $95.76 | $166K |
| Dec 19, 2025 | Thomas Tray | Principal Accounting Officer | SELL | 2.8K | $100.00 | $277K |
| Dec 19, 2025 | Thomas Tray | Principal Accounting Officer | EXERCISE | 1.0K | $95.76 | $100K |
| Dec 18, 2025 | Thomas Tray | Principal Accounting Officer | SELL | 600 | $98.25 | $59K |
| Dec 17, 2025 | Michael James Morrissey | EVP, Head of Tech. Operations | SELL | 4.3K | $97.26 | $420K |
| Dec 16, 2025 | Michael James Morrissey | EVP, Head of Tech. Operations | SELL | 53.2K | $97.29 | $5.2M |
| Dec 16, 2025 | Michael James Morrissey | EVP, Head of Tech. Operations | SELL | 833 | $97.42 | $81K |
| Dec 11, 2025 | Patrick A Mayes | EVP & Chief Scientific Officer | SELL | 255 | $94.94 | $24K |
| Dec 10, 2025 | Patrick A Mayes | EVP & Chief Scientific Officer | SELL | 5.6K | $95.58 | $531K |
| Dec 02, 2025 | Steven H Stein | EVP & Chief Medical Officer | SELL | 20.1K | $102.51 | $2.1M |
| Dec 01, 2025 | Steven H Stein | EVP & Chief Medical Officer | SELL | 2.6K | $102.96 | $263K |
| Dec 01, 2025 | Richard A. Hoffman | EVP & General Counsel | GRANT | 9.5K | — | — |